Two recently published cross-sectional studies investigated sclerostin levels in controlled acromegaly before [25, 26], although with significantly smaller patient numbers (18 and 12 controlled patients, respectively), both reporting comparable serum sclerostin levels between patients and healthy controls [25, 26]. This evidence concerns the gene SOST and acromegaly.